EPS Diluted (Quarterly) Chart

Historical EPS Diluted (Quarterly) Data

View and export this data back to 2020. Start Trial.
Date Value
June 30, 2026 -0.9133
March 31, 2026 -0.8986
December 31, 2025 -0.8018
September 30, 2025 -1.316
June 30, 2025 -1.767
March 31, 2025 -0.4377
December 31, 2024 -7.393
September 30, 2024 -1.096
June 30, 2024 -1.026
March 31, 2024 -4.730
December 31, 2023 -5.185
September 30, 2023 -90.18
Date Value
June 30, 2023 -40.97
March 31, 2023 -136.19
December 31, 2022 -165.20
September 30, 2022 -65.34
June 30, 2022 -31.15
March 31, 2022 -34.68
December 31, 2021 2.215
September 30, 2021 0.4525
June 30, 2021 -3.801
March 31, 2021 3.271
December 31, 2020 -0.01

EPS Diluted (Quarterly) Range, Past 5 Years

View EPS Diluted (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly) Benchmarks

View EPS Diluted (Quarterly) Benchmarks
Start Trial
Abbott Laboratories 0.5294
AngioDynamics, Inc. -0.1689
Alphatec Holdings, Inc. -0.0348
AtriCure, Inc. 0.0816
Baxter International, Inc. 0.5654